The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and ... long-acting muscarinic receptor antagonists (LAMA) to ICS + long-acting b2 agonist (LABA ...

another LABA/LAMA/ICS combination – is approved for chronic obstructive pulmonary disease (COPD) but was only filed for approval as an asthma therapy in Europe in February, so looks set to be ...

The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...

If you have asthma, running might worsen your symptoms, but there are precautions you can take to make it safer. Typically, symptoms like wheezing, coughing, and shortness of breath begin about 15 ...

There are many types of asthma inhalers that differ in three key ways: Whether they are used for quick relief or long-term ...

Asthma is the most common chronic disease of childhood and, in the latter part of the 20th century, reached epidemic proportions. Asthma is generally believed to result from gene-environment ...

He is, without a doubt, one of the best-known people on the planet. In an age where celebrity is worshipped, the Dalai Lama is a faith leader who has become a spiritual superstar. As he approaches ...

Asthma is a condition that affects the airways carrying air into and out of the lungs. Smoking causes lung disease, heart disease and increased risks of several different types of cancer due to ...

Their analysis shows that children's risk of developing asthma later in life can be more reliably predicted by observing the dynamic development of symptoms during the first year of life.

Lama Fakih is Human Rights Watch’s Middle East and North Africa director and the director of the Beirut office. Prior to her current role, Fakih was the Director of the Crisis and Conflict ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Philip Morris International has agreed to sell its Vectura asthma inhaler maker for only a third of what it ...

The global asthma treatment market size was valued at USD 27.51 billion in 2023 and is expected to reach around USD 35.93 billion by 2034. It is growing at a CAGR of 2.42% from 2024 and 2034. The ...